BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.710
-0.100 (-3.56%)
Mar 5, 2026, 4:00 PM EST - Market closed
BioLineRx Employees
BioLineRx had 28 employees as of December 31, 2024. The number of employees decreased by 51 or -64.56% compared to the previous year.
Employees
28
Change (1Y)
-51
Growth (1Y)
-64.56%
Revenue / Employee
$454,821
Profits / Employee
-$106,321
Market Cap
12.66M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 61 |
| CytoMed Therapeutics | 43 |
| Curis | 34 |
| Longeveron | 25 |
| BioCardia | 20 |
| Soligenix | 16 |
| NewcelX | 15 |
| Cellectar Biosciences | 11 |
BLRX News
- 3 months ago - BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioLineRx (BLRX) Surpasses Q3 EPS Estimates Despite Revenue Shortfall - GuruFocus
- 3 months ago - BioLineRx (BLRX) Q3 Revenue Declines Amid New Joint Venture - GuruFocus
- 3 months ago - BioLineRx GAAP EPS of $0.00 beats by $0.54, revenue of $0.43M misses by $0.24M - Seeking Alpha
- 3 months ago - BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Earnings Scheduled For November 24, 2025 - Benzinga
- 3 months ago - BioLine Rx's Earnings: A Preview - Benzinga
- 3 months ago - BioLineRx Q3 2025 Earnings Preview - Seeking Alpha